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PIONEER study, just more than half 
of all patients were never-smokers 
(52.6% [n = 779/1482]) and just more 
than one-fifth were regular smokers 
(22.1% [n = 327/1482]). Of the seven 
Asian countries/regions included in 
the PIONEER study, Taiwan had the 
greatest proportion of never-smokers 
(65.7%) and Vietnam had the low-
est proportion of never-smokers 
(31.4%). Similarly, Taiwanese females 
with NSCLC had the highest propor-
tion of never-smokers (97.8%) and 
Vietnamese males had the lowest pro-
portion of never-smokers (12.9%) of 
all the sex subgroups analyzed.1
Dr. Ou et al. observed driver muta-
tions in EGFR, anaplastic lymphoma 
kinase (ALK), gene encoding the proto-
oncogene tyrosine-protein kinase ROS 
enzyme (ROS1), and RET proto-ocogene 
(RET) primarily in never-smokers.2 In 
the PIONEER study, EGFR mutation 
status was evaluable in tumors from 1450 
of 1482 patients (97.8%). By country, 
EGFR mutation frequency was highest 
in patients from Vietnam (64.2% [n = 77 
of 120]) and lowest in patients from 
India (22.2% [n = 16 of 72]). Females 
had higher EGFR mutation frequency 
than males (61.1% [n = 384 of 628] and 
44.0% [n = 362 of 822], respectively) 
across all countries. Considering smok-
ing history, EGFR mutation frequency 
was highest among never-smokers 
(60.7% [n = 462 of 761]) compared with 
exsmokers (43.2% [n = 130 of 301]), 
occasional smokers (51.6% [n = 33 of 
64]), or regular smokers (37.3% [n = 121 
of 324]). EGFR mutation frequency was 
decreased as pack-year number increased 
(>0–10 pack-years: 57.9%; >50 pack-
years: 31.4%). A similar trend was 
observed by sex: males (0–10 pack-years: 
55.9% [n = 161 of 288], >10–30 pack-
years: 46.6% [n = 123 of 264], >30 pack-
years: 28.2% [n = 74 of 262]); females 
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In Response:
Dr. Ou has requested smoking sta-
tus by country/region, and by sex within 
each country/region, for the patients 
with advanced non–small-cell lung can-
cer (NSCLC) who were included in a 
molecular ePIdemiOlogy study in Asian 
patients with advanced NSCLC of adEno 
histology to assess epidermal growth 
factor receptor (EGFR) mutation status 
(PIONEER) (NCT01185314), which 
analyzed data from 1482 eligible patients 
with advanced NSCLC.1 We are pleased 
to supply below the subgroup analyses 
of smoking status data by country/region 
and by sex within each country/region in 
reply to Dr. Ou’s request (Tables 1–3).
Dr. Ou et al. previously pub-
lished that Vietnamese-American 
females with NSCLC had the highest 
proportion of never-smokers (65.5%) 
among the six Asian-American 
subgroups analyzed in their study, 
whereas Japanese-American females 
with NSCLC had the lowest propor-
tion of never-smokers (19.3%).2 In the 
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(0–10 pack-years: 62.5% [n = 371 of 
594], >10–30 pack-years: 37.5% [n = 9 
of 24], >30 pack-years: 40.0% [n = 4 of 
10]). PIONEER researchers concluded 
that a patient’s ethnicity and smoking 
status/pack years were independent pre-
dictive factors for tumor EGFR mutation 
status. Other mutations were not explored 
in PIONEER.1
Given the limited sample sizes of 
these PIONEER subgroup analyses of 
smoking status data by country/region 
and by sex, we note that interpretation 
needs to be with caution, as the analyses 
may be subject to large sampling fluctu-
ations. We thank Dr. Ou for his congrat-
ulations and interest in our study and 
hope the above is informative and use-
ful for him and other interested parties.
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TABLE 1. Smoking History by Country (PP Population)
Smoking History
Total  
(n = 1482)
China  
(n = 7 47)
Hong Kong 
(n = 170)
India  
(n = 81)
Philippines 
(n = 66)
Taiwan  
(n = 178)
Thailand 
(n = 119)
Vietnam  
(n = 1 21)
Smokinga, n (%)
  Never-smoker 779 (52.6) 421 (56.4) 77 (45.3) 47 (58.0) 36 (54.5) 117 (65.7) 43 (36.1) 38 (31.4)
  Exsmoker 310 (20.9) 136 (18.2) 29 (17.1) 26 (32.1) 15 (22.7) 32 (18.0) 52 (43.7) 20 (16.5)
  Occasional smoker 66 (4.5) 19 (2.5) 14 (8.2) 0 1 (1.5) 7 (3.9) 6 (5.0) 19 (15.7)
  Regular smoker 327 (22.1) 171 (22.9) 50 (29.4) 8 (9.9) 14 (21.2) 22 (12.4) 18 (15.1) 44 (36.4)
Pack-years, n (%)
  0–10 902 (61.2) 470 (63.1) 89 (52.7) 51 (63.8) 39 (59.1) 126 (71.2) 68 (57.1) 59 (50.0)
  >10–30 291 (19.7) 153 (20.5) 31 (18.3) 6 (7.5) 7 (10.6) 25 (14.1) 31 (26.1) 38 (32.2)
  >30 281 (19.1) 122 (16.4) 49 (29.0) 23 (28.8) 20 (30.3) 26 (14.7) 20 (16.8) 21 (17.8)
  Unknown 8 2 1 1 0 1 0 3
aSmoking history definitions: never-smoker (patients who had never smoked cigarettes in their lifetime); exsmoker (patients who had previously smoked but no longer smoked); 
occasional smoker (patients who smoked, but not every day); regular smoker (patients who smoked every day).
PP, per protocol.
TABLE 2.  Smoking History by Country in Male Patients (PP Population)
Smoking History
Total  
(n = 839)
China  
(n = 397)
Hong Kong 
(n = 106)
India  
(n = 51)
Philippines 
(n = 39)
Taiwan  
(n = 86)
Thailand 
(n = 67)
Vietnam 
(n = 93)
Smokinga, n (%)
  Never-smoker 188 (22.4) 92 (23.2) 20 (18.9) 18 (35.3) 10 (25.6) 27 (31.4) 9 (13.4) 12 (12.9)
  Exsmoker 285 (34.0) 128 (32.2) 26 (24.5) 25 (49.0) 15 (38.5) 32 (37.2) 39 (58.2) 20 (21.5)
  Occasional smoker 62 (7.4) 17 (4.3) 13 (12.3) 0 1 (2.6) 7 (8.1) 6 (9.0) 18 (19.4)
  Regular smoker 304 (36.2) 160 (40.3) 47 (44.3) 8 (15.7) 13 (33.3) 20 (23.3) 13 (19.4) 43 (46.2)
Pack-years, n (%)
  0–10 294 (35.4) 136 (34.4) 31 (29.5) 22 (44.0) 13 (33.3) 36 (42.4) 24 (35.8) 32 (35.6)
  >10–30 267 (32.1) 140 (35.4) 28 (26.7) 5 (10.0) 7 (17.9) 25 (29.4) 24 (35.8) 38 (42.2)
  >30 270 (32.5) 119 (30.1) 46 (43.8) 23 (46.0) 19 (48.7) 24 (28.2) 19 (28.4) 20 (22.2)
  Unknown 8 2 1 1 0 1 0 3
aSmoking history definitions: never-smoker (patients who had never smoked cigarettes in their lifetime); exsmoker (patients who had previously smoked but no longer smoked); 
occasional smoker (patients who smoked, but not every day); regular smoker (patients who smoked every day).
PP, per protocol.
TABLE 3.  Smoking History by Country in Female Patients (PP Population)
Smoking History
Total  
(n = 643)
China  
(n = 350)
Hong Kong 
(n = 64)
India  
(n = 30)
Philippines 
(n = 27)
Taiwan  
(n = 92)
Thailand 
(n = 52)
Vietnam 
(n = 28)
Smokinga, n (%)
  Never-smoker 591 (91.9) 329 (94.0) 57 (89.1) 29 (96.7) 26 (96.3) 90 (97.8) 34 (65.4) 26 (92.9)
  Exsmoker 25 (3.9) 8 (2.3) 3 (4.7) 1 (3.3) 0 0 13 (25.0) 0
  Occasional smoker 4 (0.6) 2 (0.6) 1 (1.6) 0 0 0 0 1 (3.6)
  Regular smoker 23 (3.6) 11 (3.1) 3 (4.7) 0 1 (3.7) 2 (2.2) 5 (9.6) 1 (3.6)
Pack-years, n (%)
  0–10 608 (94.6) 334 (95.4) 58 (90.6) 29 (96.7) 26 (96.3) 90 (97.8) 44 (84.6) 27 (96.4)
  >10–30 24 (3.7) 13 (3.7) 3 (4.7) 1 (3.3) 0 0 7 (13.5) 0
  >30 11 (1.7) 3 (0.9) 3 (4.7) 0 1 (3.7) 2 (2.2) 1 (1.9) 1 (3.6)
aSmoking history definitions: never-smoker (patients who had never smoked cigarettes in their lifetime); exsmoker (patients who had previously smoked but no longer smoked); 
occasional smoker (patients who smoked, but not every day); regular smoker (patients who smoked every day).
PP, per protocol.
